Awarded
NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B
£192,000,000
goods
Contract Details
- Tender Value
- £192,000,000
- Stage
- Awarded
- Published
- Awarded
Timeline
Awarded
Start
Disclosed
End
Description
NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. The framework will commence on 1st March 2019 for a period of 24 months until 28th February 2021, with options to extend up to a further 24 month.
Related Contracts
From This Buyer
In This Category
Ref: 4b4175f9-e4ff-4ca9-a23b-79d639ae18c9-275483 · Sourced from Contracts Finder
View source notice